De verborgen gevaren van vaccinaties - WantToKnow.nl

Aluminium hydroxide leidt tot motorische stoornissen en degeneratie van
neuronen
Op 20-8-2009 publiceerde het online ScienceDirect, het artikel Aluminium hydroxide
injections lead to motor deficits and motor neuron degeneraton, door Christopher A. Shaw
en Michael S. Petrik van de University of British Columbia, Vancouver, Canada, in het
Journal of Inorganic Biochemistry. Ik citeer hieronder het Abstract van dit artikel.
[…] Gulf War Syndrome is a multi-system disorder afflicting many veterans of Western
armies in the 1990-1991 Gulf War. A number of those afflicted may show neurological
deficits including various cognitive dysfunctions and motor neuron disease, the latter
expression virtually indistinguisable from classical amyotrophic lateral sclerosis (ALS)
except for the age of onset. This ALS-“cluster” represents the second such ALS cluster
described in the literature to date. Possible causes of GWS include several of the adjuvants in
the anthrax vaccine and others. The most likely culprit appears to be aluminium hydroxide. In
an initial series of experiments, we examined the potential toxicity of aluminium in male,
outbred CD-1 mice injected subcutaneously in two equivalent-to-human doses.
After sacrifice, spinal cord and motor cortex samples were examined by
immunohistochemistry.
Aluminium-treated mice showed significantly increased apoptosis of motor neurons and
increases in reactive astrocytes and microglial proliferation within the spinal cord and
cortex. Morin stain detected the presence of aluminium in the cytoplasm of motor neurons
with some neurons also testing positive for the presence of hyper-phosphorylated tau
protein, a pahtological hallmark of various neurological diseases, including Alzheimer’s
disease and frontotemporal dementia.
A second series of experiments was conducted on mice injected with six doses of aluminium
hydroxide. Behavioural analysis in these mice revealed significant impairments in a
number of motor functions as well as diminished spatial memory capacity.
The demonstrated neurotoxicity of aluminium hydroxide and its relative ubiquity as an
adjuvant suggest that greater scrunity by the scientific community is warranted […]
Volgens Vaccines Licensed for Immunization and Distribution in the US with Supporting Documents,
http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093830.htm, bevatten de volgende
vaccins (vaccinnaam/handelsnaam, fabrikant en informatie van het genoemde product) aluminium adjuvants.
Anthrax Vaccine Adsorbed/Biothrax, Emergent BioDefense Operations Lansing, Inc., "The final product is
formulated to contain 1.2 mg/mL aluminum, added as aluminum hydroxide in 0.85% sodium chloride."
Diphtheria & Tetanus Toxoids Adsorbed, Sanofi Pasteur Inc, "Each 0.5 mL dose is formulated to contain 6.7 Lf
of diphtheria toxoid, 5 Lf of tetanus toxoid, and not more than 0.17 mg of aluminum."
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed/Tripedia, Sanofi Pasteur, Inc., "Each
0.5 mL dose also contains, by assay, not more than 0.170 mg of aluminum and not more than 100 µg (0.02%) of
residual formaldehyde."
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed/Infanrix, GlaxoSmithKline Biologicals,
"Each 0.5-mL dose contains 4.5 mg of NaCl and aluminum adjuvant (not more than 0.625 mg aluminum by
assay). Each dose also contains ≤100 mcg of residual formaldehyde and ≤100 mcg of polysorbate 80 (Tween
80)."
Diphtheria & Tetanus Toxoids & Acellular Pertussis Vaccine Adsorbed/DAPTACEL, Sanofi Pasteur, Ltd.,
"Other ingredients per 0.5 mL dose include 1.5 mg aluminum phosphate (0.33 mg of aluminum) as the adjuvant,
≤5 µg residual formaldehyde,